Parallax Volatility Advisers, L.P. 180 Life Sciences Corp. Transaction History

Parallax Volatility Advisers, L.P.

  • $45.1 Billion
  • Q2 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
BUY
$2.51 - $6.96 $31,974 - $88,663
12,739 New
12,739 $84,000

About 180 Life Sciences Corp.

ATNF Quotes by TradingView
  • Ticker ATNF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,698,900
  • Market Cap $141M
  • Description
  • 1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...
More about ATNF
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email